Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent ... Content Above the Acceptable Daily Intake (ADI) Limit ...

Nostrum Laboratories (Kansas City, MO) announced on Nov. 2, 2020 that it was voluntarily recalling two lots of Metformin HCl Extended Release Tablets, USP 750 mg because of levels of nitrosamine (NDMA ...

Indian pharmaceutical company Marksans Pharma Limited is recalling Metformin Hydrochloride Extended-Release Tablets because its levels of NDMA, a “probable human carcinogen,” were higher than ...

Covidien (NYSE: COV), a leading global provider of healthcare products, today introduced EXALGO™ (hydromorphone HCI) Extended-Release Tablets, (CII), ...

The BEDROC trial found that extended-release ketamine tablets (R-107) significantly improve depressive symptoms in treatment-resistant depression patients, with the 180 mg dose showing the most ...

Bupropion comes as an immediate-release tablet and an extended-release tablet. Both forms are taken by mouth. Bupropion is used to treat depression and help prevent seasonal affective disorder (SAD) .

Table II: Extended-release model formulation containing propranolol hydrochloride as the active ingredient. Tablet preparation procedure. Propranolol HCl, hypromellose, and microcrystalline cellulose ...

The Metformin HCl Extended Release Tablets, USP 500 mg have been found to contain levels of nitrosamine impurities above the ADI limit of 96 ng/day as publish View full recall details at FDA.gov ...

New extended-release formulation available for around-the-clock pain management ST. LOUIS--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products, today introduced ...

Kansas City, Missouri, Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 750 mg to the consumer level. The Metformin HCl Extended ...